ASN: Elderly With Chronic Kidney Disease Benefit From SGLT2 Inhibitors
MONDAY, Nov. 2, 2026-- Sodium-glucose cotransporter 2 (SGLT2) inhibitors show significant benefits for adults aged 80 years and older with chronic kidney disease (CKD), according to a study presented at Kidney Week, the annual meeting of the...
Read more »
Pharmaceutical news
ESMO: Sacituzumab Tirumotecan Beneficial for Endometrial Cancer
ASN: Routine Kidney Function Tests Underestimate CKD in People With Cancer
ASN: Fruits and Vegetables Improve Outcomes in Stage 3 Chronic Kidney Disease
Recommendations Developed for Primary Biliary Cholangitis Management
Postop Morbidity Lower With Laparoscopic Versus Open Resection of Colorectal Liver Metastases
Autism, Intellectual Disability Linked to Higher Rates of Parkinsonism
E-Bike Injuries Among Kids Surge, With Higher Rates Of Severe Injuries
Toddler Snacks Pulled From Costco, Target, Walmart And Other Stores Over Choking Danger
Energy Drinks Can Be A Heart-Stopper For Young Adults
Menopause Hormone Therapy Doesn't Increase Women's Heart Risk, Study Finds
Rural Heart Attack Patients Three Times More Likely To Die En Route To A Hospital
More Than A Quarter Of Americans Fib To Get Antibiotics, Study Finds
Monthly News Roundup - October 2026
Living Alone Linked to Increased Risk for Death From Multiple Causes
